July 7, 2022

NEW YORK–(Firm WIRE)–#Motion–Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights laws agency, is investigating potential claims in opposition to Athira Pharma, Inc. (NASDAQ: ATHA) on behalf of lengthy-expression stockholders subsequent a category motion grievance that was filed from Athira on June 25, 2021 with a Course Time frame from September 17, 2020 to June 17, 2021. Our investigation issues whether or not the board of administrators of Athira have breached their fiduciary duties to the corporate.

On June 17, 2021, quickly after the market place shut, Athira launched that it had positioned its president and Chief Govt Officer, Dr. Leen Kawas (“Kawas”), on go away pending a analysis of actions stemming from doctoral exploration she carried out when at Washington State College (“WSU”).

The identical working day, STAT printed an write-up stating that WSU was investigating statements that Dr. Kawas “revealed quite a few papers containing altered photos while she was a graduate pupil.” These papers “are foundational to Athira’s initiatives to deal with Alzheimer’s” given that they “established {that a} particular molecule has an impact on the exercise of HGF.” Whereas Athira is growing a definite molecule than the an individual Kawas examined within the papers at scenario, her “doctoral carry out laid the natural groundwork that Athira proceeds to make use of of their strategy to managing Alzheimer’s.”

The Registration Assertion was materially pretend and misleading and omitted to state: (1) that Kawas had printed exploration papers made up of improperly altered images whereas she was a graduate pupil (2) that this purported exploration was foundational to Athira’s makes an attempt to supply therapy plans for Alzheimer’s primarily as a result of it laid the organic groundwork that Athira was making use of in its technique to treating Alzheimer’s (3) that, as a ultimate end result, Athira’s mental property and merchandise progress for the remedy of Alzheimer’s have been being based mostly totally on invalid analysis and (4) that, as a consequence of the foregoing, Defendants’ optimistic statements concerning the Firm’s enterprise, operations, and potential consumers, had been materially misleading and/or lacked a acceptable foundation.

See also  Lawyer Randall Kinnard Establishes New Regulation Agency

In case you are a really long-phrase stockholder of Athira, have info, wish to uncover extra about these claims, or have any considerations concerning this announcement or your authorized rights or passions with respect to those points, please communicate to Brandon Walker or Alexandra B. Raymond by e-mail at [email protected], or cellphone at (212) 355-4648, or by filling out this get in contact with type. There isn’t any cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally acknowledged legislation company with workplaces in New York and California. The group represents particular person and institutional buyers in industrial, securities, by-product, and different refined litigation in situation and federal courts throughout the nation. For far more info and details concerning the enterprise, bear in mind to try www.bespc.com. Authorized skilled selling. Prior results don’t assurance equivalent outcomes.

Contacts

Bragar Eagel & Squire, P.C.

Brandon Walker, Esq.

Alexandra B. Raymond, Esq.

(212) 355-4648

[email protected]
www.bespc.com